Jan 08, 02
|
| 12:49 ET |
Aviron Replies to Complete Response Letter
|
|
Nov 06, 01
|
| 07:31 ET |
Aviron Names Mike Makris Vice President, Controller
|
|
Oct 25, 01
|
| 16:06 ET |
Aviron Announces Third Quarter, Nine Month 2001 Results
|
|
Oct 19, 01
|
| 16:28 ET |
Aviron to Host Conference Call on Third Quarter 2001 Results
|
|
Sep 26, 01
|
| 19:49 ET |
Aviron Announces Management Appointments
|
|
Sep 07, 01
|
| 07:30 ET |
Aviron Names Luc Hermans Vice President & UK Site Director
|
|
Sep 03, 01
|
| 18:01 ET |
Aviron Receives Complete Response Letter Following FDA Review Of FluMist(TM) BLA
|
|
Aug 02, 01
|
| 17:09 ET |
Aviron Announces Second Quarter, First Half 2001 Results
|
|
Jul 31, 01
|
| 19:09 ET |
Aviron to Host Conference Call on Second Quarter 2001 Results
|
|
Jul 27, 01
|
| 18:24 ET |
Aviron to Host Conference Call
|
|
| 16:27 ET |
FDA Advisory Committee Evaluates FluMist(TM) Safety & Efficacy Data
|
|
Jul 26, 01
|
| 08:06 ET |
Trading Halted on Aviron Stock
|
|
Jun 26, 01
|
| 20:02 ET |
FDA Advisory Committee Scheduled to Review FluMist(TM) July 26-27
|
|
Jun 18, 01
|
| 09:00 ET |
Aviron Announces Redemption of 5 3/4 Percent Convertible Subordinated Notes Due 2005
|
|
May 21, 01
|
| 17:38 ET |
Aviron Elects Barbara Franklin to Board of Directors
|
|
Apr 25, 01
|
| 20:36 ET |
Aviron Announces First Quarter 2001 Results
|
|
Apr 23, 01
|
| 18:09 ET |
Aviron to Host Conference Call on First Quarter 2001 Results
|
|
Feb 02, 01
|
| 06:32 ET |
Aviron Prices Public Offerings of 4,000,000 Shares of Common Stock And $200 Million of 5 1/4 Percent Convertible Notes Due 2008
|
|
Jan 31, 01
|
| 18:45 ET |
Aviron Announces Fourth Quarter, Year End Results
|
|
Jan 29, 01
|
| 06:45 ET |
Aviron Announces $8 Million Financing
|
|
Jan 24, 01
|
| 08:45 ET |
Aviron Promotes Prasad to Senior Vice President, Technical Affairs
|
|
Jan 12, 01
|
| 09:03 ET |
Aviron Commences Public Offerings of 3,000,000 Shares of Common Stock And $150 Million of Convertible Notes
|
|
Jan 08, 01
|
| 22:27 ET |
Aviron Receives $10 Million Payment for Flumist(TM) Manufacturing
|
|
Dec 29, 00
|
| 16:05 ET |
FDA Accepts FluMist(TM) Biologics License Application (BLA) for Review
|
|
Dec 28, 00
|
| 19:14 ET |
Aviron Announces $8 Million Financing
|
|
Dec 18, 00
|
| 09:53 ET |
Aviron Announces Filing of Universal Shelf Registration Statement
|
|
Nov 29, 00
|
| 19:20 ET |
Aviron Announces $8 Million Financing
|
|
Oct 31, 00
|
| 16:22 ET |
Aviron Submits Biologics License Application for FluMist(TM)
|
 |
Oct 26, 00
|
| 07:00 ET |
Aviron Announces Third Quarter, Nine Month 2000 Results
|
|
Oct 25, 00
|
| 16:38 ET |
Aviron Announces Initiation of Phase 2 Clinical Trial With Epstein-Barr Virus Vaccine
|
|
Oct 11, 00
|
| 07:02 ET |
Aviron Strengthens FluMist(TM) Commercial Infrastructure With Two Transactions In United Kingdom
|
|
Oct 03, 00
|
| 18:27 ET |
Aviron Announces $8 Million Financing
|
|
Sep 29, 00
|
| 08:35 ET |
Aviron Awarded Grant to Create Vaccine for Future Influenza Pandemics
|
|
Sep 11, 00
|
| 08:00 ET |
Aviron Names Dr. Harry Greenberg Chief Scientific Officer
|
|
Sep 06, 00
|
| 17:56 ET |
Aviron Announces $8 Million Financing
|
|
Aug 30, 00
|
| 08:01 ET |
Aviron Elects Douglas to Board of Directors
|
|
Aug 08, 00
|
| 17:16 ET |
Aviron Announces $8 Million Financing
|
|
Aug 07, 00
|
| 17:28 ET |
Aviron Names New Vice Presidents of Regulatory Affairs and Manufacturing
|
|
Jul 26, 00
|
| 20:17 ET |
Aviron Announces Second Quarter, First Half 2000 Results
|
|
Jul 11, 00
|
| 18:49 ET |
Aviron Announces $8 Million Financing
|
|
Jun 30, 00
|
| 07:00 ET |
Clinical Testing Begins With Aviron CMV Vaccine
|
|
Jun 23, 00
|
| 16:05 ET |
Aviron and NIH Extend FluMist Agreement
|
|
Jun 12, 00
|
| 18:38 ET |
Aviron Announces $8 Million Financing
|
|
May 12, 00
|
| 18:36 ET |
Aviron Announces $8 Million Financing
|
|
May 11, 00
|
| 21:05 ET |
Aviron Elects Mendelson to Board of Directors
|
|
| 20:52 ET |
Aviron Promotes Arcuri to Senior Vice President, Operations
|
|
Apr 27, 00
|
| 19:06 ET |
Aviron Announces First Quarter 2000 Results
|
|
Apr 14, 00
|
| 16:05 ET |
Aviron Names Friedman Vice President and General Counsel
|
|
Apr 13, 00
|
| 18:48 ET |
Aviron Announces $4 Million Financing
|
|
Apr 06, 00
|
| 15:23 ET |
Aviron Prices Follow-On Offering
|
|
Mar 08, 00
|
| 11:18 ET |
Aviron Announces Public Offering of 3,000,000 Shares of Common Stock
|
|
Mar 07, 00
|
| 20:38 ET |
Aviron Announces Update on BLA Submission Timing
|
|
Mar 06, 00
|
| 18:15 ET |
Aviron Adds Fenton and Hockmeyer to Board of Directors
|
|
Mar 02, 00
|
| 19:02 ET |
Aviron Announces Fourth Quarter, Year End Results
|
|
Feb 17, 00
|
| 16:05 ET |
Aviron Accelerates Issuance of Warrant to University of Michigan
|
|
Feb 03, 00
|
| 16:23 ET |
Aviron Announces $8 Million Financing
|
|
Jan 12, 00
|
| 16:05 ET |
Aviron Announces $48 Million Financing Commitment
|
|
Dec 16, 99
|
| 19:33 ET |
Aviron Announces $5.3 Million Financing
|
|
Dec 14, 99
|
| 20:22 ET |
Published Data Reports Aviron's FluMist(TM) Provided Protection Against Influenza
|
|
Dec 06, 99
|
| 00:01 ET |
Aviron Names New Chief Executive Officer
|
|
Nov 18, 99
|
| 12:23 ET |
Aviron Announces $6 Million Financing
|
|
Nov 14, 99
|
| 22:12 ET |
Aviron Announces Delay of BLA Submission
|
|
| 22:09 ET |
Aviron Announces Third Quarter, Nine Month Results
|
|
Sep 16, 99
|
| 07:30 ET |
Aviron Announces Filing of Shelf Registration Statement
|
|
Sep 01, 99
|
| 16:13 ET |
Aviron Names Bluth Senior Manager, Corporate Communications
|
|
Aug 11, 99
|
| 16:05 ET |
Aviron Announces Results of Phase 1 Clinical Trial for Epstein-Barr Virus Vaccine
|
|
Aug 05, 99
|
| 16:04 ET |
Aviron Announces Second Quarter, First Half Results
|
|
Jul 26, 99
|
| 16:05 ET |
Aviron Names VPs for New Positions in Manufacturing and Technical Affairs
|
|
Jul 13, 99
|
| 16:05 ET |
JAMA Publishes Study on the Results of Aviron's FluMist(TM) in Working Adults
|
|
Jul 12, 99
|
| 13:26 ET |
Aviron, Medeva Pharma Extend Manufacturing Collaboration
|
|
Jun 09, 99
|
| 06:30 ET |
Aviron Bridging Study Completed
|
|
May 03, 99
|
| 16:05 ET |
Aviron Announces First Quarter, 1999 Results
|
|
Mar 18, 99
|
| 09:00 ET |
Global Agreement Between Aviron and Wyeth on FluMist Effective as FTC Grants Early Termination Of Review
|
|
Mar 02, 99
|
| 11:00 ET |
Aviron Names Mocca VP Regulatory Affairs
|
|
Feb 17, 99
|
| 16:05 ET |
Aviron Announces FY 1998 Results
|
|
Jan 12, 99
|
| 16:51 ET |
Aviron Provides Additional Information About Global Collaboration on FluMist(TM) with Wyeth Lederle Vaccines
|
|
Dec 10, 98
|
| 16:05 ET |
Aviron Meets With FDA Regarding FluMist(TM) License Applications
|
|
Dec 05, 98
|
| 23:00 ET |
Preliminary Results of Aviron FluMist Studies Presented at International Influenza Symposium
|
|
Nov 09, 98
|
| 16:05 ET |
Aviron Announces Third Quarter, Nine Month Results
|
|
Oct 09, 98
|
| 16:15 ET |
Aviron Clarifies Study Results Reported by the Media
|
|
Sep 27, 98
|
| 11:30 ET |
New Data Presented at ICAAC Shows Aviron's FluMist(TM) Intranasal Influenza Vaccine Provided 86% Protection Against a Variant Strain Of Influenza in Children
|
|
Aug 31, 98
|
| 00:44 ET |
Aviron Receives Non-Filable Notification From FDA on FluMist;
|
|
Aug 19, 98
|
| 16:05 ET |
Becton Dickinson and Aviron Sign Joint Supply Agreement for FluMist(TM) Intranasal Influenza Vaccine Spray Device
|
|
Aug 12, 98
|
| 11:00 ET |
Aviron Names Vorheis VP Manufacturing
|
|
Aug 11, 98
|
| 08:45 ET |
Aviron Announces Second Quarter, First Half Results
|
|
Aug 06, 98
|
| 11:05 ET |
Aviron Announces Commencement of First Study to Assess Widespread Pediatric Influenza Vaccination
|
|
Aug 04, 98
|
| 11:00 ET |
Aviron Receives Small Business Innovation Research Grant for Development Of Cytomegalovirus Vaccine
|
|
Aug 03, 98
|
| 16:03 ET |
Aviron Announces Preliminary Results From a Year-Two Phase 3 Study Of FluMist(TM) in Children
|
|
Jul 01, 98
|
| 08:31 ET |
Aviron Announces Submission of a Product License Application For FluMist(TM) - The First Intranasal Influenza Vaccine
|
|
Jun 29, 98
|
| 12:27 ET |
Aviron CEO J. Leighton Read Named Life Sciences Entrepreneur of the Year
|
|
Jun 22, 98
|
| 16:15 ET |
Aviron, CSL Limited Sign Agreement on Licensing and Distribution Of FluMist(TM), Aviron's Intranasal Influenza Vaccine
|
|
Jun 18, 98
|
| 11:00 ET |
Aviron Names Christenson Director, Corporate Communications
|
|
Jun 15, 98
|
| 11:01 ET |
Aviron Names Olson Senior Vice President, Commercial Development
|
|
May 13, 98
|
| 17:00 ET |
New England Journal of Medicine Publishes Data Showing Aviron's FluMist(TM) Vaccine Is 93% Effective Against Influenza
|
|
May 11, 98
|
| 05:30 ET |
Aviron Announces First Quarter 1998 Results
|
|
Mar 17, 98
|
| 07:00 ET |
Aviron Announces Proposed $100 Million Convertible Note Offer
|
|
Feb 24, 98
|
| 08:05 ET |
Aviron Announces Positive Results of Consistency Lot Trial
|
|
Jan 30, 98
|
| 16:06 ET |
Aviron Announces Avian Influenza Vaccine Collaboration
|
|
Jan 09, 98
|
| 16:30 ET |
Aviron Announces Naming of New Chief Financial Officer
|
|
Dec 16, 97
|
| 17:00 ET |
Aviron Announces Update on Fall Clinical Program
|
|
Dec 15, 97
|
| 16:53 ET |
Aviron Announces Update on Fall Clinical Program
|
|
Dec 03, 97
|
| 16:27 ET |
Aviron Announces Commencement of Phase I Clinical Trial of Epstein-Barr Virus Vaccine
|
|
Oct 08, 97
|
| 16:00 ET |
Aviron Adopts Shareholder Rights Plan
|
|
Sep 17, 97
|
| 16:09 ET |
Aviron and Chiron Settle Litigation
|
|
Sep 15, 97
|
| 16:28 ET |
Aviron Appoints C. Jo White, M.D. as Senior Vice President, Medical Affairs
|
|
Jul 14, 97
|
| 15:16 ET |
Nasal Spray Flu Vaccine Proves Effective in Children in NIH Study
|
|
| 15:14 ET |
NIH Announcement of Pivotal Phase III Intranasal Influenza Vaccine Trial Success
|
|
May 15, 97
|
| 13:07 ET |
Aviron and Medeva Announce Manufacturing Agreement
|
|
Apr 01, 97
|
| 11:45 ET |
Aviron Announces $15 Million in Private Financing
|
|
Mar 10, 97
|
| 16:32 ET |
Aviron Announces Third Quarter 1997 Unblinding of Phase III Influenza Vaccine Clinical Results
|
|
Sep 18, 96
|
| 10:42 ET |
Aviron Announces Gene Therapy Alliance With NeuroVir
|
|
Aug 26, 96
|
| 08:04 ET |
Aviron Initiates Pivotal Phase III Trial of Intranasal Influenza Vaccine
|
|